Thomson X Inks Strategic Partnership with Singapore-Based Startup Plano and Set Sights on Managing Myopia in Asia
TX"), a wholly-owned subsidiary of SGX Mainboard-listed Thomson Medical Group Limited (the " Group"), today announced a strategic partnership with Plano Pte Ltd (" Plano"), a Singapore-based HealthTech startup. The collaboration will leverage on the respective strengths of TX and Plano to address and manage the rapidly increasing incidence of myopia through innovative technological solutions. Myopia is steadily growing into one of the biggest public health challenges in the world, affecting an estimated 2.6 billion people globally, or about one-third of the world's population. By 2050, myop...